| 000 | 01470 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513065357.0 | ||
| 264 | 0 | _c19931209 | |
| 008 | 199312s 0 0 eng d | ||
| 022 | _a0174-4879 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aForte, P | |
| 245 | 0 | 0 |
_aEffects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology, therapy, and toxicology _cAug 1993 |
||
| 300 |
_a404-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aDomperidone _xpharmacology |
| 650 | 0 | 4 |
_aDopamine _xpharmacology |
| 650 | 0 | 4 | _aDopamine Antagonists |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xmetabolism |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 |
_aMetoclopramide _xpharmacology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRadioimmunoassay |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
| 700 | 1 | _aMartin, G | |
| 700 | 1 | _aLuchsinger, A | |
| 700 | 1 | _aHernandez, O | |
| 700 | 1 | _aRomero, E | |
| 700 | 1 | _aVelasco, M | |
| 773 | 0 |
_tInternational journal of clinical pharmacology, therapy, and toxicology _gvol. 31 _gno. 8 _gp. 404-6 |
|
| 999 |
_c8224971 _d8224971 |
||